90.80

0.46% 0.42

Haemonetics Corp (HAE)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Haemonetics Corp stock is traded at $90.80, with a volume of 533.28K. It is up +0.46% in the last 24 hours and up +22.03% over the past month. Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Previous Close:

$90.38

Open:

$90.61

24h Volume:

533.28K

Relative Volume:

0.62

Market Cap:

$4.13B

Revenue:

$1.33B

Net Income/Loss:

$97.31M

P/E Ratio:

44.69

EPS:

2.0317

Net Cash Flow:

$260.44M

1W Performance:

+3.37%

1M Performance:

+22.03%

6M Performance:

+57.20%

1Y Performance:

+73.51%

1-Day Range:

$89.82

$91.49

1-Week Range:

$85.97

$92.25

52-Week Range:

$47.31

$92.25

Haemonetics Corp Stock (HAE) Company Profile

Name

Haemonetics Corp

Sector

Healthcare (1080)

Industry

Medical Devices (141)

Phone

(781) 848-7100

Address

125 SUMMER STREET, BOSTON, MA

Employee

3,009

Twitter

@HaemoneticsCorp

Next Earnings Date

2026-08-06

Latest SEC Filings

HAE's Discussions on Twitter

Compare HAE vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HAE Haemonetics Corp	90.80	4.16B	1.33B	97.31M	260.44M	2.0317
ABT Abbott Laboratories	111.25	191.92B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	339.21	133.18B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	91.27	116.18B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	51.83	74.52B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	91.60	53.63B	6.30B	1.07B	1.09B	1.8406

Haemonetics Corp Stock (HAE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-15-25	Downgrade	Needham	Buy → Hold
Dec-11-25	Downgrade	Citigroup	Buy → Neutral
Aug-11-25	Downgrade	Raymond James	Strong Buy → Outperform
Aug-08-25	Reiterated	Barrington Research	Outperform
Aug-08-25	Downgrade	JP Morgan	Overweight → Neutral
Jul-09-25	Upgrade	Citigroup	Neutral → Buy
Jun-26-25	Initiated	Robert W. Baird	Outperform
Feb-07-25	Downgrade	BofA Securities	Neutral → Underperform
Dec-06-24	Initiated	JP Morgan	Overweight
Nov-08-24	Upgrade	Raymond James	Outperform → Strong Buy
Sep-13-24	Initiated	CL King	Buy
Sep-11-24	Initiated	BofA Securities	Neutral
Sep-10-24	Initiated	BTIG Research	Buy
Jun-12-24	Upgrade	Needham	Hold → Buy
Oct-13-22	Initiated	Mizuho	Buy
Jan-27-22	Downgrade	Needham	Buy → Hold
Dec-15-21	Downgrade	Citigroup	Buy → Neutral
Aug-17-21	Resumed	Raymond James	Outperform
Jun-17-21	Initiated	Citigroup	Buy
May-14-21	Upgrade	CJS Securities	Market Perform → Market Outperform
Apr-20-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Apr-19-21	Downgrade	CJS Securities	Market Outperform → Market Perform
Feb-03-21	Upgrade	Barrington Research	Mkt Perform → Outperform
Jan-21-21	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-05-20	Upgrade	Barrington Research	Mkt Perform → Outperform
May-06-20	Downgrade	Barrington Research	Outperform → Mkt Perform
Mar-31-20	Upgrade	CJS Securities	Market Perform → Market Outperform
Jan-10-20	Initiated	Needham	Buy
Aug-07-19	Reiterated	Barrington Research	Outperform
May-14-19	Upgrade	Raymond James	Mkt Perform → Outperform
May-08-19	Reiterated	Barrington Research	Outperform
Aug-09-18	Reiterated	Barrington Research	Outperform
Feb-07-18	Reiterated	Barrington Research	Outperform
Jan-02-18	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Nov-08-17	Reiterated	Barrington Research	Outperform
Aug-08-17	Upgrade	Barrington Research	Mkt Perform → Outperform
Jul-13-17	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform
Feb-07-17	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-08-16	Upgrade	Barrington Research	Mkt Perform → Outperform
Nov-07-16	Reiterated	The Benchmark Company	Hold
Sep-20-16	Downgrade	CJS Securities	Market Outperform → Market Perform
Aug-15-16	Downgrade	Sidoti	Buy → Neutral
Aug-02-16	Reiterated	Jefferies	Buy
Aug-02-16	Reiterated	The Benchmark Company	Hold

View All

Haemonetics Corp Stock (HAE) Latest News

Aug 14, 2026

John Rogers's Top Q2 2026 Move: Haemonetics Corp at a 1.54% Portfolio Impact - Yahoo Finance

Aug 14, 2026

Assenagon Asset Management S.A. Sells 142,292 Shares of Haemonetics Corporation $HAE - MarketBeat

Aug 14, 2026

Aug 13, 2026

Haemonetics (HAE) Q1 2027 Earnings Call Transcript - AOL.com

Aug 13, 2026

Haemonetics Corporation (NYSE:HAE) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Aug 13, 2026

Aug 12, 2026